BRIEF published on 02/28/2025 at 19:33, 1 month 2 days ago Adocia Completes €9.7 Million Private Placement Private Placement Share Capital Biopharmaceutical Diabetes Treatment ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 1 month 2 days ago Inside Information / Other news releases Adocia successfully settles and delivers €9.7 million private placement, issuing 2,125,000 new ordinary shares with warrants. Admittance to trading on Euronext Paris confirmed Private Placement Euronext Paris Diabetes Biopharmaceutical ADOCIA
BRIEF published on 02/26/2025 at 08:47, 1 month 4 days ago ADOCIA strengthens its cash flow with a private placement of 9.7 million euros Private Placement Capital Increase Biopharmaceutical Third Party Capital Financial Tonnage
PRESS RELEASE published on 02/26/2025 at 08:42, 1 month 4 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Adocia successfully completes €9.7 million private placement, extending cash runway to Q2 2026. New shares issued with warrants attached. Notable investors include Gerard Soula and Armistice Capital Private Placement Investors New Shares Cash Runway ADOCIA
BRIEF published on 02/25/2025 at 19:08, 1 month 5 days ago Adocia: Financial report for the fourth quarter of 2024 Diabetes Treasury Partnership ADOCIA BioChaperone®
PRESS RELEASE published on 02/25/2025 at 19:03, 1 month 5 days ago Inside Information / News release on accounts, results Adocia reports Q4 2024 financial results, €7.5M cash position, partnership updates with Sanofi, and business priorities. Strong revenue growth detailed in press release Financial Results Revenue Growth ADOCIA Partnership Updates Business Priorities
BRIEF published on 02/11/2025 at 14:03, 1 month 19 days ago Threshold crossing at ADOCIA by the CDC Actions Threshold Crossing Bpifrance ADOCIA Deposit Fund
BRIEF published on 12/23/2024 at 18:40, 3 months 10 days ago Adocia announces its participation in key conferences in 2025 Investors Biopharmaceutical ADOCIA Conférences 2025 Diabetes And Obesity
BRIEF published on 08/30/2024 at 08:05, 7 months 3 days ago ADOCIA: Information on shares and voting rights as of July 31, 2024 Voting Rights Actions Biopharmaceutical July 31, 2024 ADOCIA
Published on 04/03/2025 at 01:35, 3 hours 41 minutes ago GMV Minerals Inc. Closes Non-Brokered Financing/ Engages Investor Relations Firm
Published on 04/02/2025 at 23:35, 5 hours 41 minutes ago Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 9 hours 16 minutes ago Network-1 Announces Acquisition of Patent Portfolio
Published on 04/02/2025 at 15:00, 14 hours 16 minutes ago Doubleview Gold Corp 2025 Exploration Program
Published on 04/02/2025 at 20:20, 8 hours 55 minutes ago EQS-Adhoc: Siemens Aktiengesellschaft: Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences
Published on 04/02/2025 at 20:01, 9 hours 14 minutes ago Annual General Meeting of Deutsche Konsum REIT-AG successfully held
Published on 04/02/2025 at 20:01, 9 hours 14 minutes ago Travis Perkins: Publication of the Annual Report and Accounts 2024
Published on 04/02/2025 at 19:40, 9 hours 35 minutes ago LION E-Mobility AG starts successfully into the new 2025 financial year – Challenging market environment impacts 2024
Published on 04/02/2025 at 19:13, 10 hours 3 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/03/2025 at 00:37, 4 hours 38 minutes ago Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
Published on 04/02/2025 at 17:45, 11 hours 31 minutes ago Aéroports de Paris SA - Voting rights as of 31 March 2025
Published on 04/02/2025 at 17:45, 11 hours 31 minutes ago Availability of the Pre-Q1 2025 Sales Communication
Published on 04/02/2025 at 17:45, 11 hours 31 minutes ago Information concerning the total number of voting rights and shares 2025 03 31
